News
AKYA
2.490
-2.35%
-0.060
Weekly Report: what happened at AKYA last week (1209-1213)?
Weekly Report · 5d ago
Market Cool On Akoya Biosciences, Inc.'s (NASDAQ:AKYA) Revenues Pushing Shares 29% Lower
Simply Wall St · 12/14 12:21
Akoya Biosciences and NeraCare Forge Exclusive Global License Agreement for Immunoprint Test Development in Melanoma Care
Barchart · 12/10 17:22
Akoya Biosciences and NeraCare enter into a license agreement
Seeking Alpha · 12/10 14:41
Akoya Biosciences, NeraCare enter exclusive global license agreement
TipRanks · 12/10 13:35
AKOYA BIOSCIENCES AND NERACARE ENTER INTO AN EXCLUSIVE GLOBAL LICENSE AGREEMENT FOR THE DEVELOPMENT AND COMMERCIALIZATION OF THE IMMUNOPRINT TEST FOR EARLY-STAGE MELANOMA PATIENT TREATMENT DECISIONS
Reuters · 12/10 13:15
Akoya Biosciences and NeraCare Enter into an Exclusive Global License Agreement for the Development and Commercialization of the Immunoprint Test for Early-Stage Melanoma Patient Treatment Decisions
Barchart · 12/10 07:15
Weekly Report: what happened at AKYA last week (1202-1206)?
Weekly Report · 12/09 09:01
Biotech Advances Drive Cancer Research as Global Rates Continue Upward Trend
Barchart · 12/02 09:18
Weekly Report: what happened at AKYA last week (1125-1129)?
Weekly Report · 12/02 09:01
Weekly Report: what happened at AKYA last week (1118-1122)?
Weekly Report · 11/25 09:01
Akoya Biosciences Price Target Cut to $3.00/Share From $4.00 by Piper Sandler
Dow Jones · 11/19 17:22
Piper Sandler Reiterates Overweight on Akoya Biosciences, Lowers Price Target to $3
Benzinga · 11/19 17:12
Akoya Biosciences price target lowered to $3 from $4 at Piper Sandler
TipRanks · 11/19 11:30
Revenue Downgrade: Here's What Analysts Forecast For Akoya Biosciences, Inc. (NASDAQ:AKYA)
Simply Wall St · 11/19 10:40
Analysts Offer Insights on Healthcare Companies: Akoya Biosciences (AKYA), OncoCyte (OCX) and Healthequity (HQY)
TipRanks · 11/18 10:10
Weekly Report: what happened at AKYA last week (1111-1115)?
Weekly Report · 11/18 09:00
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 11/15 21:06
Akoya stock plunges 30% on outlook as Craig-Hallum cuts to hold
Seeking Alpha · 11/15 19:59
BUZZ-U.S. STOCKS ON THE MOVE-FuelCell Energy, consumer goods stocks, Rocket Companies
Reuters · 11/15 18:47
More
Webull provides a variety of real-time AKYA stock news. You can receive the latest news about Akoya Biosciences, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About AKYA
Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery, clinical research, and diagnostics. It offers single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. It offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research: PhenoCode Panels and PhenoCycler, PhenoImager Fusion and PhenoImager HT Instruments. Its PhenoCycler platform provides ultra-high parameter biomarker discovery, with the ability to analyze high-plex single-cell resolution across the entire tissue sample. Its PhenoImager platform enables researchers to visualize, analyze, quantify and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded (FFPE) tissue sections, and tissue microarrays (TMAs).